ArthroPeptin: Low-Molecular Peptide Complex for Joint & Ligament Health

ArthroPeptin is an innovative joint health supplement formulated with a low-molecular-weight peptide complex for superior cartilage regeneration and overall joint support. This unique formula, featuring the patented IPH® AEN/DES chondropeptide complex, is clinically proven to stimulate cartilage repair and strengthen connective tissues.

Unlike many chondroprotective agents that rely on poorly absorbed glucosamine and chondroitin, ArthroPeptin leverages the power of short tripeptides. These tiny peptides (IPH® AEN, molecular weight 330 Da) readily penetrate the intestinal lining, ensuring optimal bioavailability and targeted delivery to cartilage cells. This significantly surpasses the absorption rates of larger molecules like chondroitin (13% absorption) and glucosamine (25%), where only a small fraction reaches the cartilage.

The IPH® AEN peptide complex works by signaling cells to increase the production of essential proteins, including elastin, contributing to improved joint flexibility and elasticity. This process is further enhanced by the synergistic action of additional components:

• Collagen Hydrolysate: Supports cartilage structure and regeneration.
• Low-Molecular Hyaluronic Acid: Provides lubrication and reduces inflammation.
• Eggshell Membrane Hydrolysate: Offers additional anti-inflammatory and pain-relieving benefits. The synergistic action of the eggshell membrane hydrolysate with the IPH® AEN peptide positively influences the production of desmosine (DES), a crucial component of elastin, further enhancing joint flexibility.

The IPH® peptides, sourced from deep-sea fish and produced using a patented process by IDEAL PHARMA PEPTIDE® GmbH (Germany), are organically derived, safe, non-habit-forming, and hypoallergenic. Their efficacy and safety are supported by certifications from the Ministry of Agriculture, Forestry and Fisheries of Japan (Declaration number: JS1391CN15520) and the Kobe Chamber of Commerce and Industry (Certificate of origin number: 91-0015, August 30, 2019). IPH® peptides are approved for use in Europe, the USA, and Russia and hold GMP, ISO, FDA, HALAL, and KOSHIR certifications.

Recommended Dosage: 412 mg per day.